Additionally, the alterations in SOX4, such as mutation, amplification, and deep deletion, showed a high percentage in various cancer types, including bladder, prostate, and ovarian cancer datasets, with alteration frequencies of 17%, 16%, and 14%, respectively. Here, SOX4 is linked to ovarian carcinoma.